As for the European populations, ABCB1 rs1045642 G and ABCB1 rs2032582 C variants are rather frequent (around 50 %) in all of them, and could be relevant for reduced clearance of azithro mycin, lopinavir and ritonavir drugs in COVID-19 patients. This evidence concerns the gene ABCB1 and COVID-19.